Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients

YY Wang; MA Bahar; AM Jansen; JWH Kocks; JWC Alffenaar; E Hak; B Wilffert; Sander Borgsteede

doi:10.1093/jac/dkz221

Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients

YY Wang
, MA Bahar
, AM Jansen
, JWH Kocks
, JWC Alffenaar
, E Hak
, B Wilffert
, Sander Borgsteede

Pharmacy

Research output: Contribution to journal › Article › Academic › peer-review

8 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	2848-2864
Number of pages	17
Journal	Journal of Antimicrobial Chemotherapy
Volume	74
Issue number	10
DOIs	https://doi.org/10.1093/jac/dkz221
Publication status	Published - 2019

Research programs

EMC OR-01

Access to Document

10.1093/jac/dkz221

http://hdl.handle.net/1765/119888

Cite this

Wang, YY., Bahar, MA., Jansen, AM., Kocks, JWH., Alffenaar, JWC., Hak, E., Wilffert, B., & Borgsteede, S. (2019). Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients. Journal of Antimicrobial Chemotherapy, 74(10), 2848-2864. https://doi.org/10.1093/jac/dkz221

@article{5eb3f16b58f945e896291a8bf0adf584,

title = "Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients",

author = "YY Wang and MA Bahar and AM Jansen and JWH Kocks and JWC Alffenaar and E Hak and B Wilffert and Sander Borgsteede",

year = "2019",

doi = "10.1093/jac/dkz221",

language = "Undefined/Unknown",

volume = "74",

pages = "2848--2864",

journal = "Journal of Antimicrobial Chemotherapy",

issn = "0305-7453",

publisher = "Oxford University Press",

number = "10",

}

Wang, YY, Bahar, MA, Jansen, AM, Kocks, JWH, Alffenaar, JWC, Hak, E, Wilffert, B & Borgsteede, S 2019, 'Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients', Journal of Antimicrobial Chemotherapy, vol. 74, no. 10, pp. 2848-2864. https://doi.org/10.1093/jac/dkz221

Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients. / Wang, YY; Bahar, MA; Jansen, AM et al.
In: Journal of Antimicrobial Chemotherapy, Vol. 74, No. 10, 2019, p. 2848-2864.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients

AU - Wang, YY

AU - Bahar, MA

AU - Jansen, AM

AU - Kocks, JWH

AU - Alffenaar, JWC

AU - Hak, E

AU - Wilffert, B

AU - Borgsteede, Sander

PY - 2019

Y1 - 2019

U2 - 10.1093/jac/dkz221

DO - 10.1093/jac/dkz221

M3 - Article

SN - 0305-7453

VL - 74

SP - 2848

EP - 2864

JO - Journal of Antimicrobial Chemotherapy

JF - Journal of Antimicrobial Chemotherapy

IS - 10

ER -

Wang YY, Bahar MA, Jansen AM, Kocks JWH, Alffenaar JWC, Hak E et al. Improving antibacterial prescribing safety in the management of COPD exacerbations: systematic review of observational and clinical studies on potential drug interactions associated with frequently prescribed antibacterials among COPD patients. Journal of Antimicrobial Chemotherapy. 2019;74(10):2848-2864. doi: 10.1093/jac/dkz221